{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"11"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"12"}],"units":"Participants"}],"groups":[{"description":"Our protocol is designed to attempt to improve the current results of matched unrelated donor allogeneic bone marrow transplant (MUD allo BMT) and will be a major step towards the introduction and refinement of graft engineering. Our approach will address in a rational fashion all major technical and clinical aspects of MUD allo BMT.\n\nPeripheral blood lymphocyte therapy; cyclophosphamide, tacrolimus, peripheral blood stem cell transplantation; total-body irradiation; allogeneic hematopoietic stem cell transplantation;\n\nperipheral blood lymphocyte therapy: T-cell depletion\n\ncyclophosphamide: T-cell depletion\n\ntacrolimus: T-cell depletion\n\nallogeneic hematopoietic stem cell transplantation: T-cell depletion\n\nperipheral blood stem cell transplantation: T-cell depletion\n\ntotal-body irradiation: T-cell depletion","id":"OG000","title":"T-Cell Depletion Transplant"}],"paramType":"NUMBER","reportingStatus":"POSTED","timeFrame":"D+100 from transplant","title":"The Rate of Acute Graft Versus Host Disease (GVHD)","type":"SECONDARY","unitOfMeasure":"participants"}